Urban Select Capital Corp. (TSX VENTURE:CH) announced today that it has entered
into a cooperative partnership agreement with Eidam Diagnostics Corporation as
of March 22, 2013. 


Eidam Diagnostics Corporation, ("Eidam") based in Richmond, British Columbia, is
a manufacturer and distributor of medical devices. The CRT 2000(R) Thermographic
System is Eidam's primary product. The CRT 2000 is a revolutionary diagnostic
tool useful for practitioners in both preventative alternative and conventional
healthcare, and draws on proprietary analysis methods created from patient
profiles spanning more than 25 years. As of February 2013, Eidam has received
U.S. FDA, European CE and SFDA China Class II certifications and approvals for
the CRT 2000. Eidam also has established manufacturing, sales, and distribution
of the CRT 2000 in diverse geographical markets, including North America, Asia
and Europe. 


According to the framework of the cooperative partnership agreement, Eidam has
granted Urban Select an exclusive ten-year sole agent license to distribute the
CRT 2000 in the China, Hong Kong and Taiwan regions with an option to further
extend this license for an additional ten years through to 2033. Eidam will
provide the CRT 2000 devices and personnel training related to the operations of
the CRT 2000. Urban Select will be compensated according to a net profit sharing
agreement with Eidam by which Urban Select will earn 80% of the net profits and
Eidam will earn the remaining 20%. In addition, Urban Select can earn up to a
total of 3 million bonus Eidam common shares based on specific incremental sales
milestones being achieved every year from July 2013 to June 2017. 


Joseph F. Fodor, Chairman of the Board of Directors of Urban Select Capital
Corporation stated, "As the world's most populated country, China offers one of
the largest markets for medical devices such as the CRT 2000. Since 2009,
China's growth in the medical equipment market has outgained its general
economic growth and we are excited that the government has committed to develop
the country's healthcare system to provide universal healthcare access for all
by 2020. As the country's healthcare industry improves its medical
infrastructure systems, we are confident this will lead to increased spending in
medical equipment and devices. As a result, we feel very privileged to have the
opportunity to work together with the team at Eidam Diagnostics to provide the
Chinese market with a proven, quality product in the CRT 2000 which addresses
critical issues necessary for an ageing population with rising medical costs. We
look forward to developing a mutually beneficial long-term relationship with
Eidam in the China market." 


About Eidam Diagnostics Corporation

Eidam Diagnostics Corporation is a privately held Canadian company headquartered
in Richmond, British Columbia. Eidam's primary product is the CRT 2000(TM)
Thermographic System (the "Product"), which is a non-invasive, radiation-free,
reproducible thermographic tool that measures the temperature of pre-determined
skin points and analyzes such data to provide a healthcare practitioner with
information that may be indicative of irregular body function. The Product has
obtained the CE Mark, is available for sale in the United States based upon its
FDA premarket notification (510(k)) and is also certified as a Class II medical
device by the Chinese health authority. The Product was developed based on the
intellectual property acquired from Capital 21 Holdings Corporation, a related
corporate entity to Eidam.


About Urban Select Capital Corporation

Urban Select Capital Corporation is an investment issuer focused on investing
growth capital into private and public companies in a broad range of sectors
including renewable energy, natural resources, chemicals, agriculture and
consumer retail services. Urban Select's management team is composed of
investment professionals combining an Asian background with Western education
and extensive experience in investment banking, venture capital and fund
management in Canada, China and the U.S.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Urban Select Capital Corporation
David Yoo
Chief Financial Officer and Corporate Secretary
(604) 689-0618
Charbone Hydrogen (TSXV:CH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Charbone Hydrogen.
Charbone Hydrogen (TSXV:CH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Charbone Hydrogen.